Genetic recombination pathways and their application for genome modification of human embryonic stem cells.
Human embryonic stem cells are pluripotent cells derived from early human embryo and retain a potential to differentiate into all adult cell types. They provide vast opportunities in cell replacement therapies and are expected to become significant tools in drug discovery as well as in the studies of cellular and developmental functions of human genes. The progress in applying different types of DNA recombination reactions for genome modification in a variety of eukaryotic cell types has provided means to utilize recombination-based strategies also in human embryonic stem cells. Homologous recombination-based methods, particularly those utilizing extended homologous regions and those employing zinc finger nucleases to boost genomic integration, have shown their usefulness in efficient genome modification. Site-specific recombination systems are potent genome modifiers, and they can be used to integrate DNA into loci that contain an appropriate recombination signal sequence, either naturally occurring or suitably pre-engineered. Non-homologous recombination can be used to generate random integrations in genomes relatively effortlessly, albeit with a moderate efficiency and precision. DNA transposition-based strategies offer substantially more efficient random strategies and provide means to generate single-copy insertions, thus potentiating the generation of genome-wide insertion libraries applicable in genetic screens.
Nieminen
Mikko
M
Division of Genetics and Physiology, Department of Biology, University of Turku, Turku, Finland.
Tuuri
Timo
T
Savilahti
Harri
H
D000328:Adult; D053595:Embryonic Stem Cells / Q000166:cytology* / Q000378:metabolism*; D005818:Genetic Engineering; D015894:Genome, Human; D006801:Humans; D011995:Recombination, Genetic; D015398:Signal Transduction